Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis

被引：0
|
作者：
Nadav Michaan
Moshe Leshno
Yoni Cohen
Tamar Safra
Shira Peleg-Hasson
Ido Laskov
Dan Grisaru
机构：
[1] Tel Aviv University,Gynecologic Oncology Department, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Sackler School of Medicine
[2] Tel Aviv University,Gastro
[3] Tel Aviv University,enterology, Tel Aviv Sourasky Medical Center, Coller School of Management and Sackler School of Medicine
[4] Sackler School of Medicine,In
[5] Tel Aviv University,vitro Fertilization Unit, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Sackler School of Medicine
来源：
Reproductive Biology and Endocrinology | / 19卷
关键词：
IFV/PGT-M; BRCA; Cost-effectiveness; Ovarian cancer; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers
    Hopper, John L.
    Dowty, James G.
    Apicella, Carmel
    Southey, Melissa C.
    Giles, Graham G.
    Winship, Ingrid
    JOURNAL OF MEDICAL GENETICS, 2008, 45 (07) : 409 - 410
  • [32] Cost-effectiveness of surveillance and prevention strategies in BRCA 1/2 mutation carriers.
    Yamauchi, Hideko
    Nakagawa, Chizuko
    Kobayashi, Makoto
    Kobayashi, Yusuke
    Mano, Toshiki
    Nakamura, Seigo
    Arai, Masami
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers
    Yamauchi, Hideko
    Nakagawa, Chizuko
    Kobayashi, Makoto
    Kobayashi, Yusuke
    Mano, Toshiki
    Nakamura, Seigo
    Arai, Masami
    BREAST CANCER, 2018, 25 (02) : 141 - 150
  • [34] Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers
    Hideko Yamauchi
    Chizuko Nakagawa
    Makoto Kobayashi
    Yusuke Kobayashi
    Toshiki Mano
    Seigo Nakamura
    Masami Arai
    Breast Cancer, 2018, 25 : 141 - 150
  • [35] The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers
    Teppala, Srinivas
    Scuffham, Paul
    Edmunds, Kim
    Roberts, Matthew
    Fairbairn, David
    Smith, David
    Horvath, Lisa
    Tuffaha, Haitham
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 208 - 208
  • [36] preimplantation genetic testing for carriers of balanced chromosomal rearrangements
    Yacuts, O.
    Tsukerman, J.
    Zhabinskaya, A.
    Alekseeva, A.
    Volokhanovitch, S.
    Tishkevich, O.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 883 - 883
  • [37] Cost Effectiveness Analysis of Genetic Testing for Breast and Ovarian Cancer Susceptibility Genes: BRCA1 and BRCA2
    Kaldate, Rajesh
    Huston, Alissa
    McCoy, Heidi
    Cardeiro, Dawn
    Noyes, Katia
    BREAST JOURNAL, 2014, 20 (03): : 325 - 326
  • [38] Preimplantation genetic screening in older women: a cost-effectiveness analysis
    Mersereau, Jennifer E.
    Plunkett, Beth A.
    Cedars, Marcelle I.
    FERTILITY AND STERILITY, 2008, 90 (03) : 592 - 598
  • [39] Timing of genetic testing in BRCA mutation carriers: an unfortunate lost opportunity for those meeting NCCN testing criteria
    Lee, Sarah
    Finning, Skyler
    Rajeev, Pournami
    Pothuri, Bhavana
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S310 - S310
  • [40] Should genetic testing for BRCA1/2 be permitted for minors?: Opinions of BRCA mutation carriers and their adult offspring
    Bradbury, Angela R.
    Patrock-Moller, Ldnda
    Pawlowski, Kimberly
    Ibe, Comfort N.
    Cummongs, Shelly A.
    Olopade, Olufunmilayo I.
    Daugherty, Christopher K.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2008, 148C (01) : 70 - 77
12345